<DOC>
	<DOC>NCT02421601</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of SI-6603(Condoliase) in patients with lumbar disc herniation.</brief_summary>
	<brief_title>A Study of SI-6603 in Patients With Lumbar Disc Herniation</brief_title>
	<detailed_description />
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Patients with lumbar disc herniation (L1L2, L2L3, L3L4, L4L5 or L5S1) as assessed by MRI and clinical symptoms corresponding to position of the impaired nerve root. Patients assessed as positive in the Femoral Nerve Stretching (FNS) test for L1L2, L2L3, or L3L4 and Straight Leg Raising (SLR) test. Patients with sciatica in either leg. Patients with no improvement from conservative treatment Patients who have 2 or more lumbar disc herniations as assessed by MRI. Patients in whom a rupture into the posterior longitudinal ligament is identified by MRI. Patients who have undergone lumbar operation, or lumbar percutaneous nucleotomy or lumbar intradiscal therapies</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>